Ledger.Open graph →
SEC Form D · filed March 28, 2017

Taiga Biotechnologies, Inc

Offering
$20.0M
Sold
$6.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
AURORA, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

James C. Kelly · Aurora, CODirectorYosef L. Refaeli · Aurora, COExec · DirectorBrian C. Turner · Aurora, COExec · DirectorDaniel L. Ritchie · Aurora, CODirectorJerry Kochanski · Summit, NJExec · DirectorJerry Kochanski · Relationship(s): Executive Off, NJExec · DirectorJasvir Kaloti · Vancouver, British Columbia, CanadaDirectorGreg Fleishman · Pacific Palisades, CADirectorChristopher Biasotti · New York, NYDirectorEmily Deboer · Denver, COExec · DirectorRobin Deterding · Boulder, COExec · DirectorJeremy Prager · Englewood, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗